These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18251181)

  • 1. p53 is an indicator of tumor progression in early but not advanced gastric carcinomas.
    Ishii HH; Gobe GC; Ebihara Y
    Hepatogastroenterology; 2007; 54(79):2159-63. PubMed ID: 18251181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
    Pan W; Ishii H; Ebihara Y; Gobe G
    J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
    Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD
    Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas.
    Ishii HH; Gobe GC; Yoneyama J; Mukaide M; Ebihara Y
    J Clin Pathol; 2004 Dec; 57(12):1306-11. PubMed ID: 15563673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in clinicopathological findings, cell kinetics and p53 expression between early gastric cancers with and without Helicobacter pylori infection.
    Mitsuhashi J; Mitomi H; Tanabe S; Koizumi W; Kikuchi S; Ojima T; Okayasu I; Saigenji K
    Hepatogastroenterology; 2004; 51(60):1636-40. PubMed ID: 15532794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
    Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
    J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
    Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
    Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of p53 expression and cell proliferation in gastric carcinomas. An immunohistochemical study.
    Gonda G; Bajtai A; Nagy P; Szántó I; Kiss J
    Hepatogastroenterology; 2004; 51(55):273-6. PubMed ID: 15011884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis.
    Mikami T; Yanagisawa N; Baba H; Koike M; Okayasu I
    Cancer; 1999 Jan; 85(2):318-25. PubMed ID: 10023698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of different biological markers (DNA index, PCNA index, apoptosis, p53, karyotype) in 126 adenocarcinoma gastric biopsies.
    Matturri L; Biondo B; Cazzullo A; Colombo B; Giordano F; Guarino M; Pallotti F; Turconi P; Lavezzi AM
    Anticancer Res; 1998; 18(4B):2819-25. PubMed ID: 9713468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
    Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mucin, p53 protein and Ki-67 expressions in gastric differentiated-type intramucosal neoplastic lesions obtained from endoscopic mucosal resection samples: a proposal for a new classification of intramucosal neoplastic lesions based on nuclear atypia.
    Sugai T; Inomata M; Uesugi N; Jiao YF; Endoh M; Orii S; Nakamura S
    Pathol Int; 2004 Jun; 54(6):425-35. PubMed ID: 15144402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of the probability of skin metastasis in gastric cancer.
    Inadomi T; Tan M; Suzuki H; Shigematsu C
    Eur J Dermatol; 1999; 9(3):214-7. PubMed ID: 10210788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype.
    Shibata N; Watari J; Fujiya M; Tanno S; Saitoh Y; Kohgo Y
    Hum Pathol; 2003 Jan; 34(1):32-40. PubMed ID: 12605364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status.
    Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
    J Exp Ther Oncol; 1996 Mar; 1(2):88-94. PubMed ID: 9414392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and immunohistochemical analyses of p53 independently predict regional metastasis of gastric cancers.
    Shiao YH; Palli D; Caporaso NE; Alvord WG; Amorosi A; Nesi G; Saieva C; Masala G; Fraumeni JF; Rice JM
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):631-3. PubMed ID: 10868700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and cell proliferation in the development of gastric carcinomas: associations with c-myc and p53 protein expression.
    Ishii HH; Gobé GC; Pan W; Yoneyama J; Ebihara Y
    J Gastroenterol Hepatol; 2002 Sep; 17(9):966-72. PubMed ID: 12167117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of p53 and Ki-67 immunohistochemical analysis for preoperative diagnosis of extremely well-differentiated gastric adenocarcinoma.
    Niimi C; Goto H; Ohmiya N; Niwa Y; Hayakawa T; Nagasaka T; Nakashima N
    Am J Clin Pathol; 2002 Nov; 118(5):683-92. PubMed ID: 12428787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.